RESEARCH-USE BIOSIMILAR ANTIBODY
Adebrelimab
Monoclonal antibody · IgG4
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC).
TARGETPDL1
YMonoclonal antibody
CATALOGSC-BS-790
CATALOG NUMBERSC-BS-790
MOLECULAR WEIGHTApprox. 145.56 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC).
Adebrelimab is a recombinant research-use antibody directed against PDL1.